| IDIVX | RMFCX | IDIVX / RMFCX | |
| Total Expense Ratio | 0.95 | 0.91 | 104% |
| Annual Report Gross Expense Ratio | 1.46 | 0.91 | 160% |
| Fund Existence | 14 years | 23 years | - |
| Gain YTD | 14.685 | 12.617 | 116% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 569M | 110B | 1% |
| Annual Yield % from dividends | 2.52 | 1.21 | 209% |
| Returns for 1 year | 6.81 | 5.59 | 122% |
| Returns for 3 years | 36.78 | 27.75 | 133% |
| Returns for 5 years | 80.26 | 51.85 | 155% |
| Returns for 10 years | 122.26 | 84.46 | 145% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CPAI | 38.74 | 0.04 | +0.10% |
| Counterpoint Quantitative Equity ETF | |||
| TIER | 27.75 | N/A | N/A |
| T. Rowe Price International Equity Research ETF | |||
| SAMM | 29.00 | -0.04 | -0.15% |
| Strategas Macro Momentum ETF | |||
| THW | 12.58 | -0.08 | -0.63% |
| abrdn World Healthcare Fund | |||
| FEZ | 61.44 | -0.77 | -1.24% |
| SPDR® EURO STOXX 50 ETF | |||